Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 282 Results
Age
Type
Conditions or Disease:

PhIII MultiCentreMulti-NationalControl Tria Inves1cmv2cm WideExcision Margins Primary Cutaneous Mela

Maki Yamamoto

  • OPEN TO ACCRUAL

D6970C00002: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Participants

Ekamol Tantisattamo

  • OPEN TO ACCRUAL

A Phase 2 Randomized, Double-blind, Placebo-controlled Study

Felice Lin

  • OPEN TO ACCRUAL

A Long-term Follow-up Study of Sotatercept for PAH Treatment

Bassam Yaghmour

  • OPEN TO ACCRUAL

PhI/II Study of HM43239 in Patients with Relapsed or Refractory AML

Deepa Jeyakumar

  • OPEN TO ACCRUAL

PhIb/II IntravesInstillation of TARA-002 in Adults w/High-grade Non-muscle Invasive Bladder Cancer

Edward Uchio

  • OPEN TO ACCRUAL

PhIII TrialSingFractionStereotacticRadiosurgVSFractionatedSRS IntactBrainMets

Aaron Simon

  • OPEN TO ACCRUAL

Phase 1 Trial of Iadademstat in Combination with Venetoclax and Azacitidine

Kiran Naqvi

  • OPEN TO ACCRUAL

OpenLabe DoseEscal PhI/II StudyTAK-676 SingleAge&Comb w/Pembrolizumab inAdult Pa w/Adv orMetaSolidTu

Rupali Nabar

  • OPEN TO ACCRUAL

Metronomic Cyclophosphamide with Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma

Warren A Chow

  • OPEN TO ACCRUAL

Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin

Alpesh Amin

  • OPEN TO ACCRUAL

A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safety

Pengbo Jiang

  • OPEN TO ACCRUAL

PhIb AMG 193 Alone or Comb w/OtherTherapies in Sbjcts w/AdvThoracicTumors w/Homozygous MTAPDeletion

Miguel Villalona-Calero

  • OPEN TO ACCRUAL

ph3 Telitacicept In Patients With Generalized Myastenia Gravis

Ali Habib

  • OPEN TO ACCRUAL

FIH Study of IK-595 Oral Dual MEK/RAF Inhibitor in Pts W/ RAS- Or RAF- Altered Adv Solid Tumors

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

ARC-311 for Patients with Non-Oncology Plasma Cell-Related Diseases

Ali Habib

  • OPEN TO ACCRUAL

A Phase 2, Open-Label, Multicentre Study of KYV-101 in Subjects with Refractory Generalized Myasthe

Ali Habib

  • OPEN TO ACCRUAL

study to validate a serum-based biomarkers panel to detect mucosal healing in moderate-to-severe UC

Nimisha Parekh

  • OPEN TO ACCRUAL

Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease

Nicolas Phielipp

  • OPEN TO ACCRUAL